Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.27
(-44.94%)
USD 0.27
(-44.94%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 7.33 Million USD | 7.58% |
| 2022 | 6.81 Million USD | 31.59% |
| 2021 | 5.17 Million USD | 60.9% |
| 2020 | 3.21 Million USD | 24.48% |
| 2019 | 2.58 Million USD | 26.98% |
| 2018 | 2.03 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 11.76 Million USD | 0.0% |
| 2024 Q1 | 11.76 Million USD | 60.51% |
| 2023 Q4 | 7.33 Million USD | 0.03% |
| 2023 Q1 | 7.17 Million USD | 5.24% |
| 2023 FY | 7.33 Million USD | 7.58% |
| 2023 Q3 | 7.32 Million USD | 2.2% |
| 2023 Q2 | 7.17 Million USD | 0.0% |
| 2022 Q4 | 6.81 Million USD | 0.0% |
| 2022 Q3 | 6.81 Million USD | 23.36% |
| 2022 FY | 6.81 Million USD | 31.59% |
| 2022 Q2 | 5.52 Million USD | 0.0% |
| 2022 Q1 | 5.52 Million USD | 6.67% |
| 2021 Q1 | 5.11 Million USD | 58.81% |
| 2021 FY | 5.17 Million USD | 60.9% |
| 2021 Q4 | 5.17 Million USD | 0.0% |
| 2021 Q2 | 5.11 Million USD | 0.0% |
| 2021 Q3 | 5.17 Million USD | 1.32% |
| 2020 Q3 | 3.21 Million USD | -24.46% |
| 2020 Q4 | 3.21 Million USD | 0.0% |
| 2020 Q2 | 4.26 Million USD | 0.0% |
| 2020 Q1 | 4.26 Million USD | 64.78% |
| 2020 FY | 3.21 Million USD | 24.48% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 2.58 Million USD | 26.98% |
| 2019 Q4 | 2.58 Million USD | 0.0% |
| 2019 Q3 | 2.58 Million USD | 0.0% |
| 2018 FY | 2.03 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 91.446% |
| AngioDynamics, Inc. | 5.91 Million USD | -23.962% |
| AtriCure, Inc. | 74.49 Million USD | 90.159% |
| Avinger, Inc. | 15.39 Million USD | 52.38% |
| Azenta, Inc. | 60.43 Million USD | 87.87% |
| BioLife Solutions, Inc. | 42.69 Million USD | 82.827% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 99.715% |
| Daxor Corporation | 755.65 Thousand USD | -870.164% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -2.276% |
| Femasys Inc. | 6.7 Million USD | -9.406% |
| GlucoTrack, Inc. | 196 Thousand USD | -3640.374% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 82.86% |
| Hologic, Inc. | 2.53 Billion USD | 99.711% |
| ICU Medical, Inc. | 1.7 Billion USD | 99.57% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 91.836% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -64.925% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | 61.607% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 99.244% |
| Microbot Medical Inc. | 231 Thousand USD | -3073.651% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 99.178% |
| Nephros, Inc. | 1.83 Million USD | -299.299% |
| NovoCure Limited | 596.24 Million USD | 98.77% |
| NEXGEL, Inc. | 2.79 Million USD | -162.013% |
| NEXGEL, Inc. | 2.79 Million USD | -162.013% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 90.263% |
| OraSure Technologies, Inc. | 13.5 Million USD | 45.711% |
| Pro-Dex, Inc. | 13.54 Million USD | 45.884% |
| Pulse Biosciences, Inc. | 9.14 Million USD | 19.826% |
| Predictive Oncology Inc. | 2.85 Million USD | -156.619% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -113.458% |
| QuidelOrtho Corporation | 2.61 Billion USD | 99.72% |
| Repligen Corporation | 711.8 Million USD | 98.97% |
| Sanara MedTech Inc. | 11.79 Million USD | 37.83% |
| STAAR Surgical Company | 35.83 Million USD | 79.541% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -2043.606% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.681% |
| Jin Medical International Ltd. | 4.11 Million USD | -78.243% |